Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Licensing deals
Pharma
Boehringer-SBP, Fresenius-WuXi Bio, Evommune—Fierce Pharma Asia
BI formed a $7.4 billion tie-up with SBP. Fresenius collaborates with WuXi Bio in sweeping biosimilars deal. Evommune got a molecular glue from China.
Angus Liu
Nov 6, 2026 8:04am
COINS Act, Hengrui, Samsung Biologics—Fierce Pharma Asia
Oct 23, 2026 8:42am
Fierce Biotech
Treasury COINS rules add biotech, spares China licensing deals
Oct 22, 2026 11:36pm
Fierce Biotech
China looks to ban foreign acquisitions of key biotech platforms
Oct 16, 2026 10:38am
Teva, Samsung Bioepis deepen biosimilar bonds with new deal
Oct 2, 2026 10:00am
AZ-Summit, Novo-Hengrui, Merck—Fierce Pharma Asia
Oct 2, 2026 9:35am